pillbase.ru

ОБИНУТУЗУМАБ

Active substance: obinutuzumab

субстанция-раствор, [замороженный], ~, (original in Russian, GRLS)

RussiaActive

Marketing holder: Ф.Хоффманн-Ля Рош Лтд

Verified 2026-10-09 · GRLS (Russian state register)

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • Gazyva
    INJECTION, SOLUTION, CONCENTRATE · OBINUTUZUMAB 1000 mg/40mL
    50242-070
    Genentech, Inc.
EU 1
  • Gazyvaro
    obinutuzumab
    EMEA/H/C/002799
    Roche Registration GmbH
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-3ce8-7062-831f-fae418f3351a,01a120c5-b040-785d-9419-af69b7762dd7;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-5efd-7c02-88ba-185feac18d6e;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
ФС-001905
Registration status
Active
Release forms
субстанция-раствор, [замороженный], ~, - контейнеры криогенные - Не указано; (original in Russian, GRLS)
Sources
  • product · GRLS (Russian state register) · ФС-001905 · Verified 2026-10-09
  • registration_status · GRLS (Russian state register) · ФС-001905 · Verified 2026-10-09
  • ingredients.0 · GRLS (Russian state register) · ФС-001905 · Verified 2026-10-09